Trade Summary

1 week ago, Hopper Jonathan Mark, serving as Chief Medical Officer at Vericel Corp (VCEL), sold 3,472 shares at $35.00 per share, for a total transaction value of $121,520.00. Following this transaction, Hopper Jonathan Mark now holds 75,556 shares of VCEL.

This sale represents a 4.00% decrease in Hopper Jonathan Mark's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Vericel Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.